These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 22588654

  • 21. [Syndrome of inadequate ADH secretion: pitfalls in diagnosis and therapy].
    Schäffler A, Lindner U.
    Dtsch Med Wochenschr; 2015 Mar; 140(5):343-6. PubMed ID: 25734677
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
    Jamookeeah C, Robinson P, O'Reilly K, Lundberg J, Gisby M, Ländin M, Skov J, Trueman D.
    BMC Endocr Disord; 2016 May 16; 16(1):22. PubMed ID: 27184496
    [Abstract] [Full Text] [Related]

  • 23. SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
    De Las Peñas R, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Álvarez Y, Rodríguez CA, Virizuela JA, López López R.
    Support Care Cancer; 2016 Jan 16; 24(1):499-507. PubMed ID: 26431960
    [Abstract] [Full Text] [Related]

  • 24. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH, Bohm NM, Nemecek BD, Crawford R, Kelley D, Bhasin B, Nietert PJ, Velez JCQ.
    Am J Kidney Dis; 2018 Jun 16; 71(6):772-782. PubMed ID: 29478867
    [Abstract] [Full Text] [Related]

  • 25. Onset of confusion in the context of late-life depression.
    Mulsant BH.
    J Psychiatry Neurosci; 2007 Mar 16; 32(2):152. PubMed ID: 17353943
    [No Abstract] [Full Text] [Related]

  • 26. A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine.
    Koelkebeck K, Domschke K, Zwanzger P, Hetzel G, Lang D, Arolt V.
    World J Biol Psychiatry; 2009 Mar 16; 10(4 Pt 2):609-11. PubMed ID: 17965988
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of hyponatremia: new developments and controversies].
    Hensen J.
    Dtsch Med Wochenschr; 2011 Apr 16; 136(17):904-9. PubMed ID: 21523644
    [Abstract] [Full Text] [Related]

  • 28. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
    Ramamohan V, Mladsi D, Ronquest N, Kamat S, Boklage S.
    Hosp Pract (1995); 2017 Aug 16; 45(3):111-117. PubMed ID: 28449624
    [Abstract] [Full Text] [Related]

  • 29. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
    Petereit C, Zaba O, Teber I, Lüders H, Grohé C.
    BMC Pulm Med; 2013 Aug 29; 13():55. PubMed ID: 23987478
    [Abstract] [Full Text] [Related]

  • 30. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
    Tzoulis P, Waung JA, Bagkeris E, Carr H, Khoo B, Cohen M, Bouloux PM.
    Clin Endocrinol (Oxf); 2016 Apr 29; 84(4):620-6. PubMed ID: 26385871
    [Abstract] [Full Text] [Related]

  • 31. Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: Two case reports.
    Sato A, Yasui-Furukori N, Oda Y, Yang M, Suzuki Y, Shinozaki M, Shimizu T, Shimoda K.
    Neuropsychopharmacol Rep; 2022 Sep 29; 42(3):387-390. PubMed ID: 35733329
    [Abstract] [Full Text] [Related]

  • 32. Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report.
    Twardowschy CA, Bertolucci CB, Gracia Cde M, Brandão MA.
    Arq Neuropsiquiatr; 2006 Mar 29; 64(1):142-5. PubMed ID: 16622573
    [Abstract] [Full Text] [Related]

  • 33. Fluoxetine-induced SIADH: most likely in the elderly?
    Burke D, Franker S.
    Aust N Z J Psychiatry; 1996 Apr 29; 30(2):299-301. PubMed ID: 8811278
    [No Abstract] [Full Text] [Related]

  • 34. Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice.
    Rajendran R, Grossman AB, Kar P.
    Endocr J; 2012 Apr 29; 59(10):903-9. PubMed ID: 22785335
    [Abstract] [Full Text] [Related]

  • 35. Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device.
    Nakamura M, Sunagawa O, Kugai T, Kinugawa K.
    Int Heart J; 2017 Dec 12; 58(6):1004-1007. PubMed ID: 29151494
    [Abstract] [Full Text] [Related]

  • 36. [77-year-old female with hyponatremia, pruritus and papulous exanthema].
    Brock J, Karrasch T, Roller FC, Steiner D, Nilles M, Blau W, Gattenlöhner S, Schäffler A.
    Dtsch Med Wochenschr; 2015 Jun 12; 140(13):997-1000. PubMed ID: 26115135
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
    Bordi P, Tiseo M, Buti S, Regolisti G, Ardizzoni A.
    Tumori; 2015 Apr 28; 101(2):e51-3. PubMed ID: 25702667
    [Abstract] [Full Text] [Related]

  • 38. A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Wada K, Matsukawa U, Fujimori A, Arai Y, Sudoh K, Sasamata M, Miyata K.
    Biol Pharm Bull; 2007 Jan 28; 30(1):91-5. PubMed ID: 17202666
    [Abstract] [Full Text] [Related]

  • 39. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
    Gargani L, Schmidt PH, Gheorghiade M.
    Expert Rev Cardiovasc Ther; 2011 Dec 28; 9(12):1505-13. PubMed ID: 22103869
    [Abstract] [Full Text] [Related]

  • 40. Tolvaptan is successful in treating inappropriate antidiuretic hormone secretion in infants.
    Marx-Berger D, Milford DV, Bandhakavi M, Van't Hoff W, Kleta R, Dattani M, Bockenhauer D.
    Acta Paediatr; 2016 Jul 28; 105(7):e334-7. PubMed ID: 27028950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.